A detailed history of River Park Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, River Park Advisors, LLC holds 3,016 shares of LLY stock, worth $2.4 Million. This represents 2.22% of its overall portfolio holdings.

Number of Shares
3,016
Previous 2,455 22.85%
Holding current value
$2.4 Million
Previous $2.22 Million 20.21%
% of portfolio
2.22%
Previous 1.86%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$772.14 - $960.02 $433,170 - $538,571
561 Added 22.85%
3,016 $2.67 Million
Q2 2024

Jul 26, 2024

BUY
$724.87 - $909.04 $97,132 - $121,811
134 Added 5.77%
2,455 $2.22 Million
Q1 2024

May 03, 2024

BUY
$592.2 - $792.28 $183,582 - $245,606
310 Added 15.42%
2,321 $1.81 Million
Q4 2023

Jan 11, 2024

BUY
$525.19 - $619.13 $360,280 - $424,723
686 Added 51.77%
2,011 $1.17 Million
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $575,977 - $794,072
1,325 New
1,325 $711,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track River Park Advisors, LLC Portfolio

Follow River Park Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Park Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Park Advisors, LLC with notifications on news.